Patterns of treatment switching and healthcare resource utilization differences among real-world Medicare patients with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX

被引：0
|
作者：
Dieguez, Gabriela
Hirsch, Jared
Cockrum, Paul
Bhatt, Prachi
Tomicki, Samantha
Kim, George P.
机构：
[1] Milliman Inc, New York, NY USA
[2] Ipsen Biopharmaceut Inc, Crowley, TX USA
[3] George Washington Univ, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16286
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Real-world healthcare resource utilization and costs in patients with chronic lymphocytic leukemia: differences between patients treated with first-line ibrutinib or bendamustine plus rituximab
    Irwin, Debra
    Wilson, Kathleen
    Thompson, Stephen
    Choudhry, Azhar
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 623 - 628
  • [42] Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database
    Studer, Sean
    Hull, Michael
    Pruett, Janis
    Koep, Eleena
    Tsang, Yuen
    Drake, William, III
    PULMONARY CIRCULATION, 2018, 9 (01)
  • [43] First-line systemic real-world treatment of patients with advanced/metastatic NSCLC in the UK
    Wang, M.
    Dhokia, P.
    Menon, S.
    Martindale, B.
    ANNALS OF ONCOLOGY, 2018, 29 : 22 - 22
  • [44] INCIDENCE OF NEUTROPENIA IN PATIENTS RECEIVING EITHER NABPACLITAXEL PLUS GEMCITABINE OR FOLFIRINOX AS FIRST-LINE TREATMENT FOR METASTATIC PANCREATIC ADENOCARCINOMA
    Parisi, M.
    Patel, M.
    Belk, K.
    Craver, C. W.
    VALUE IN HEALTH, 2016, 19 (03) : A141 - A141
  • [45] Overall survival and treatment patterns among real-world patients with locally advanced or metastatic urothelial carcinoma treated with first-line therapy
    Simeone, Jason C.
    Nordstrom, Beth L.
    Patel, Ketan
    Klein, Alyssa B.
    Horne, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [46] Overall survival (OS) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with first-line (1L) FOLFIRINOX (FFX): Bridging the gap between the NAPOLI 3 trial and real-world practice.
    Cockrum, Paul
    Chang, Rose
    Yu, Louise Huafeng
    Xu, Chunyi
    Duh, Mei Sheng
    Kim, George P.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [47] Real-world treatment patterns, healthcare resource utilization and costs among patients with peripheral T-cell lymphoma
    Dharmani, Charles
    Unni, Sudhir
    Pham, Ngan
    Shaikh, Nazneen Fatima
    Xiong, Yan
    Vashi, Rohan
    Fofah, Oluwatosin
    Strubing, Alessandria
    Salas, Maribel
    Tu, Nora
    Wooddell, Margaret
    Zhou, Xiaoyu
    Near, Aimee
    FUTURE ONCOLOGY, 2024, 20 (15) : 1013 - 1030
  • [48] Treatment patterns and healthcare resource utilization among patients with alopecia areata: A real-world chart review in South Korea
    Kwon, Ohsang
    Wallace, Matthew
    Messina, Paolo
    Szende, Agota
    Choi, Jee Woong
    Newson, Rachel S.
    Koo, Dong Hyun
    Lee, Joo Hee
    JOURNAL OF DERMATOLOGY, 2024, 51 (12): : 1622 - 1633
  • [49] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE UNITED STATES
    Pizzicato, Lia
    Nadipelli, Vijay R.
    Samuel, Governor
    Mao, Jianbin
    Lanes, Stephan
    Butler, John
    Pepe, Rebecca S.
    Phatak, Hemant
    El-Kersh, Karim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1677 - 1677
  • [50] Comparison of first-line (1L) treatment (tx) patterns and overall survival by age at diagnosis among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).
    Elias, Rawad
    Cockrum, Paul
    Surinach, Andy
    Wang, Shu
    Chu, Bong Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
12345